Tenecteplase was associated with a higher rate of complete reperfusion compared with alteplase in a study of stroke patients with LVOs undergoing thrombolysis and mechanical thrombectomy.Read More
A two-center study finds that the enhanced timeliness of care mobile stroke units bring to ischemic stroke applies to intracerebral hemorrhage as well.
Although the nationwide Target: Stroke initiative has yielded substantial improvements in thrombolytic treatment for patients of all racial and ethnic groups, residual disparities persist.
Radiological evidence of inflammation related to CAA is relatively common and most cases may go undetected and untreated, a Cleveland Clinic study shows.
Targeting the dentate nucleus with deep brain stimulation was safe and feasible for promoting post-stroke rehabilitation in a first-in-human study. Enrollment in a controlled phase II trial is underway.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Door-to-needle times for intravenous thrombolytic therapy matter even for ischemic stroke patients who later undergo thrombectomy, a large cohort study finds.
A newly published case series bolsters support for the off-label use of flow-diverting stents in this rare condition.
Retrospective studies provide mixed results on a direct-to-angiography approach for select mobile stroke unit patients and positive findings on mechanical thrombectomy beyond the 24-hour window.
A pre/post study finds that a structured transition-of-care program can cut 30-day hospital readmissions for stroke patients roughly in half. An architect of the program shares advice for others.
Multidisciplinary researchers are charting new territory in the understanding of how cerebral autoregulation is impaired in patients with advanced liver failure.
A study of a novel virtual clinic for patients discharged from the neuro ICU shows that these patients receive frequent pharmacotherapy adjustments. The findings highlight opportunities to optimize outcomes and curb adverse events in a high-risk population.